Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Neurology
|
January 13, 2012
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy
T Schneider-Hohendorf, N Schwab, N Uçeyler, et al.
Der Nervenarzt
|
August 9, 2003
[Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators]
O Neuhaus, H Wiendl, B C Kieseier, et al.
Der Nervenarzt
|
June 8, 2011
[Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications]
S Bittner, K Höhn, K Göbel, et al.
Der Nervenarzt
|
July 17, 2004
[Multiple sclerosis: potential therapeutic options and update of ongoing studies]
H Wiendl, H C Lehmann, R Hohlfeld, et al.
Clinical and Experimental Immunology
|
December 8, 2007
Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells
L Airas, M Saraste, S Rinta, et al.
Der Nervenarzt
|
August 17, 2006
[Revision of McDonald's new diagnostic criteria for multiple sclerosis]
H Wiendl, B C Kieseier, R Gold, et al.
Der Nervenarzt
|
December 8, 2004
[Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis]
O Stüve, S Nessler, H P Hartung, et al.
Annals of Neurology
|
October 12, 2000
Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G
H Wiendl, L Behrens, S Maier, et al.
Journal of Neurology
|
November 14, 2008
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations
, H Wiendl, K V Toyka, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 18, 2006
Why a positive genetic test for myotonic dystrophy type I does not always imply the right diagnosis
S G Meuth, C Kleinschnitz, M Frank, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Neurology
|
January 13, 2012
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy
T Schneider-Hohendorf, N Schwab, N Uçeyler, et al.
Der Nervenarzt
|
August 9, 2003
[Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators]
O Neuhaus, H Wiendl, B C Kieseier, et al.
Der Nervenarzt
|
June 8, 2011
[Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications]
S Bittner, K Höhn, K Göbel, et al.
Der Nervenarzt
|
July 17, 2004
[Multiple sclerosis: potential therapeutic options and update of ongoing studies]
H Wiendl, H C Lehmann, R Hohlfeld, et al.
Clinical and Experimental Immunology
|
December 8, 2007
Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells
L Airas, M Saraste, S Rinta, et al.
Der Nervenarzt
|
August 17, 2006
[Revision of McDonald's new diagnostic criteria for multiple sclerosis]
H Wiendl, B C Kieseier, R Gold, et al.
Der Nervenarzt
|
December 8, 2004
[Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis]
O Stüve, S Nessler, H P Hartung, et al.
Annals of Neurology
|
October 12, 2000
Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G
H Wiendl, L Behrens, S Maier, et al.
Journal of Neurology
|
November 14, 2008
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations
, H Wiendl, K V Toyka, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 18, 2006
Why a positive genetic test for myotonic dystrophy type I does not always imply the right diagnosis
S G Meuth, C Kleinschnitz, M Frank, et al.
Page
of 8